Thyroid Cancer Patients clinical trials

Explore recruiting thyroid cancer patients clinical trials.

Recruiting thyroid cancer patients studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Thyroid Cancer Patients trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Multicentric phase III trial comparing two strategies in intermediate-risk differentiated thyroid cancer patients: Systematic radioiodine administration versus decision of radioiodine treatment guided by a post-operative work-up based on serum Tg values and diagnostic RAI scintigraphy

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Cabozantinib (XL184) at 60 mg/Day Compared to 140 mg/Day in Progressive, Metastatic Medullary Thyroid Cancer Patients

Hungary, Poland, Romania, Croatia

Therapeutic use (Phase IV) EU CTIS Study details

Thyroid Cancer Patients trials by city

Thyroid Cancer Patients clinical trials

Recruiting thyroid cancer patients studies right now

Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer

A Study of Online Follow-up in Patients With Papillary Thyroid Cancer

A Study of DEG6498 in Participants With Solid Tumors

Ganoderma Spores Modulate the Gut-Brain Axis

TSH Suppression During Radiotherapy on Thyroid Site to Prevent Iatrogenic Hypothyroidism in Pediatric Cancer Patients

Study of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid Cancer

EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study

Agnostic Therapy in Rare Solid Tumors

A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors

Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid Carcinoma

Also recruiting in Europe

Multicentric phase III trial comparing two strategies in intermediate-risk differentiated thyroid cancer patients: Systematic radioiodine administration versus decision of radioiodine treatment guided by a post-operative work-up based on serum Tg values and diagnostic RAI scintigraphy

A Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Cabozantinib (XL184) at 60 mg/Day Compared to 140 mg/Day in Progressive, Metastatic Medullary Thyroid Cancer Patients

Thyroid Cancer Patients trials by city

Other conditions